GÖTEBORG, Sweden, April 27, 2017 /PRNewswire/ --
The 2017 Assar Gabrielsson award is presented to Joydeep Bhadury for his important research that provides a better understanding of the development of cancer and in the future can contribute to the effective treatment of various cancer types.
Cancer develops by stepwise changes in growth characteristics of the cells that may be caused by genetic and epigenetic changes and environmental factors. With the use of new molecular biological methods the analyses of the biological mechanisms behind cancer development have started and generated new important knowledge.
Joydeep Bhadury has in this thesis presented important translational cancer research that provides a better understanding of how genetic changes are related to the initiation and development of cancer.
"The results of this research can contribute to identify new targets for future effective treatments of various cancer types", says Professor Eva Forssell-Aronsson, executive member of the Assar Gabrielsson Foundation.
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a foundation to provide funding for clinical research into cancer diseases was created in 1962. It primarily supports research projects which are considered to be promising but which do not yet have the necessary weight to attract grants from central funds.
The Assar Gabrielsson Award will be presented Thursday May 18 between 12.30 and 14.00 in the Birgit Thilander room at the Academicum at Sahlgrenska Academy, Gothenburg. During the ceremony the award winner will present his research. The ceremony will be held in English.
Journalists who would like further information, please contact:
Professor of Radiation Physics and Executive member of the Assar Gabrielsson Foundation phone: +46-703722626
Senior Vice president, Research & Innovation policy, Volvo Group and Chair of the Assar Gabrielsson Foundation phone: +46-739028661
For more stories from the Volvo Group, please visit www.volvogroup.com/press.
The Volvo Group is one of the world's leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs about 95,000 people, has production facilities in 18 countries and sells its products in more than 190 markets. In 2016 the Volvo Group's sales amounted to about SEK 302 billion (EUR 31,9 billion). The Volvo Group is a publicly-held company headquartered in Göteborg, Sweden. Volvo shares are listed on Nasdaq Stockholm. For more information, please visit www.volvogroup.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/volvo---assar-gabrielsson-award-for-effective-treatment-of-cancer-300447005.html